EVIDENCE LIBRARY
Italian Community-Hospital Survey Found Midazolam Access Alongside Pediatric Sedation Training Gaps
A staff survey found that midazolam was widely available while many respondents reported limited sedation knowledge. It assessed reported practice and knowledge, not patient complication rates.
A staff survey found that midazolam was widely available while many respondents reported limited sedation knowledge. It assessed reported practice and knowledge, not patient complication rates.
The survey findings
The study analyzed 346 completed questionnaires from physicians and nurses at four secondary-care hospitals during 2021–2022. Midazolam was the most accessible and commonly used medication in the responses.
More than half reported inadequate knowledge, and only minorities demonstrated adequate answers concerning fasting and monitoring. Most respondents participated in fewer than four pediatric sedations per month. Training was frequently identified as a barrier.
Availability is not competence or harm
A hospital stocking midazolam does not show how it was administered in an individual procedure. Knowledge-test performance likewise cannot be translated directly into an adverse-event rate.
The questionnaire was developed for this study and lacked formal validation. The four hospitals were a small, geographically unbalanced sample, limiting national generalization. Self-report and participation can also affect results.
Useful application
The findings support examining training, monitoring knowledge, and local sedation processes together. They do not prove that a particular clinician lacked competence or that midazolam caused harm at a surveyed hospital. Those questions require the actual procedure record and evidence of practice rather than facility-level survey percentages.
Source paper
Original analysis of the supplied journal article, identified as PMC12838452.